Viz.ai
A hospital care coordination platform that uses AI to analyse CT scans, ECGs and echocardiograms, flag suspected time-critical conditions such as large vessel occlusion stroke or pulmonary embolism, and alert the right specialists on their phones so treatment decisions happen faster.
● Use Cases
- →Flagging suspected large vessel occlusion strokes on CT scans
- →Alerting stroke and cardiology teams through a mobile app
- →Coordinating transfers between regional and comprehensive stroke centres
- →Identifying patients with suspected pulmonary embolism for follow-up
- →Finding patients who may qualify for clinical trials
● Tags
● Listed In
About Viz.ai
What is Viz.ai?
A hospital care coordination platform that uses AI to analyse CT scans, ECGs and echocardiograms, flag suspected time-critical conditions such as large vessel occlusion stroke or pulmonary embolism, and alert the right specialists on their phones so treatment decisions happen faster. Viz.ai is an AI healthcare tool that supports clinical workflows, administrative tasks, patient communication, and medical data analysis — always operating within healthcare compliance frameworks.
Viz.ai's algorithms hold US FDA clearances, but US clearance does not mean it can be supplied here. In Australia, software that analyses medical images to support diagnosis is regulated by the TGA as software as a medical device, so check the ARTG for each specific module before procurement. Patient images and alerts are health information under the Privacy Act 1988 and state health records laws. Health services should also ask about data hosting, integration with local PACS and EMR systems, and clinical governance for AI alerts.
How Australian Businesses Use Viz.ai
Australian healthcare providers use AI tools for appointment scheduling, clinical note transcription, patient triage, insurance verification, and literature review — freeing clinical staff to focus on direct patient care.
Key Features
- ✓AI analysis of CT, ECG and echo studies for suspected time-critical conditions
- ✓Mobile app alerts specialists and shares images and results securely
- ✓Care coordination between regional spoke hospitals and comprehensive centres
- ✓Clinical suites covering neurology, cardiology, vascular, trauma and pulmonary conditions
- ✓Agent Studio lets health systems configure custom AI care pathways in plain language
Best For
- →Hospital networks running hub-and-spoke stroke services
- →Cardiology and vascular teams managing time-critical referrals
- →Health systems identifying patients who may suit clinical trials
Pros & Cons of Viz.ai
✓ Strengths
- +Focuses on time-critical conditions where speed of treatment matters
- +Mobile alerts put images and results in front of specialists quickly
- +Covers neurology, cardiology, vascular, trauma and pulmonary suites
- +Supports hub-and-spoke networks between regional and major hospitals
⚠ Limitations
- –Only relevant to hospitals and health networks
- –Australian regulatory status must be checked module by module
- –Needs integration with imaging and hospital IT systems
- –Alerts support clinicians but never replace formal radiology reporting
Pricing
Sold to hospitals and health systems under enterprise agreements, usually by clinical suite and site. There is no public price list or trial for individuals. Contact the vendor through viz.ai for an assessment of your imaging and clinical workflow.
Details checked against the vendor's website in October 2026. Pricing changes often, so confirm current plans at viz.ai.
Data Residency & Privacy in Australia
Viz.ai does not publish details of an Australian hosting region on its website. Because the platform handles patient images, alerts and clinical messages, Australian health services should ask where data is stored and processed, whether it leaves Australia, how long it is retained, and whether de-identified data is used to develop algorithms. State health departments may also have rules on offshore storage of patient information.
Need AI that keeps client data onshore? See private AI hosted in Australia.
Getting Started with Viz.ai in Australia
Viz.ai is available directly at viz.ai. Verify the tool's compliance with Australian Privacy Act, My Health Records Act, and relevant TGA requirements before implementation. Start with administrative workflows (scheduling, documentation) rather than clinical decision support until your team is confident in the system.
Outside help is most useful when the tool has to connect to existing systems, handle personal information, or be rolled out to a whole team. AI Lab Australia works with businesses across Sydney, Melbourne, Brisbane, Perth and Adelaide on that setup.
Alternatives to Viz.ai
If Viz.ai is not the right fit for your workflow, these tools serve a similar purpose and are worth evaluating:
Frequently Asked Questions About Viz.ai
Is Viz.ai available in Australia?
Viz.ai is a US company that sells mainly to US hospitals. Before any Australian deployment, check whether the specific modules you want are on the Australian Register of Therapeutic Goods, because FDA clearance does not authorise supply here. Then ask about local support, PACS integration and how alerts fit existing stroke protocols.
Does Viz.ai replace a radiologist?
No. Viz.ai flags suspected findings and notifies care teams so they can look sooner, but it does not issue a diagnostic report. Formal reporting by a radiologist or specialist still applies, and health services need clinical governance covering missed alerts, false positives and who acts on each notification.
Where does Viz.ai store patient data?
The vendor does not publish an Australian hosting option. Health services should request a data flow diagram showing where images and alerts go, which cloud regions are used, and how the arrangement meets the Privacy Act 1988, state health records laws and any jurisdictional rules on storing patient data offshore.
Ready to Implement Viz.ai?
AI Lab Australia helps Australian businesses choose, set up and connect tools like Viz.ai to the systems they already run, with privacy and data handling sorted before rollout.